J&J Wants Rivals' Marketing Data In Omnicare FCA Row

Law360, Washington (November 10, 2011, 2:58 PM EST) -- Johnson & Johnson on Wednesday demanded to see documents on other pharmaceutical makers' marketing practices that are allegedly relevant to two whistleblower actions brought by Omnicare Inc. employees claiming J&J paid tens of millions of dollars in kickbacks to Omnicare that resulted in false Medicaid claims.

A former Omnicare pharmacist acting as qui tam relator, intervening states and the U.S. government allege in Massachusetts federal court that J&J paid Omnicare to disregard cheaper rival drugs and promote J&J products to nursing homes nationwide. The payments caused...
To view the full article, register now.

UK Financial Services

UK Financial Services

Read Our Latest UK Financial Services Coverage

Financial Services Law360 UK provides breaking news and analysis on the financial sector. Coverage includes UK and European Union policy, enforcement, and litigation involving banks, asset management firms, and other financial services organizations.